I co-founded Transcera in 2020 to translate discoveries from the Lencer and Chinnapen labs at Harvard and Boston Children's Hospital. Transcera harnesses the membrane trafficking biology of sphingolipids to unlock the potential of biologic medicines for people living with chronic disease.